Building Blocks

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Chloromethyl cyclohexyl carbonate is a new acyclic nucleoside phosphonate that has been shown to have antiviral properties. It is active against HIV strains and inhibits the production of clotting factors. Chloromethyl cyclohexyl carbonate can be used as a drug substance for treating bowel disease, hepatitis, and cancer. It also modulates syncytial cells and heterocycles. Pharmacokinetic studies on chloromethyl cyclohexyl carbonate have shown that it has high bioavailability in the small intestine and liver after oral administration. It is metabolized by tyrosine kinase, which indicates that it may interfere with other drugs such as warfarin or phenytoin. Chloromethyl cyclohexyl carbonate has been found to be effective in treating gastritis and cancer in animal models.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Cyclopentylpropan-2-one (1CPA) is an aliphatic hydrocarbon that has been shown to act as a light-sensitive molecule. It is used as a polymerization initiator and is also found in the human body as a metabolic intermediate. 1CPA is found in the form of a diacylglycerol and can be converted into an allyl carbonate, which reacts with methoxy groups to form an allyl ether. 1CPA has also been shown to have structural similarities with pyrimidine compounds and formyl groups. The 1CPA molecule contains a carbonyl group, which is the reactive functional group that allows for this chemical to react with other compounds.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>2-Hydroxy-[1,1'-biphenyl]-3-carboxylic acid (2HBC) is a monomer that belongs to the group of ester compounds. It has been shown to inhibit the growth of trichophyton mentagrophytes and other fungi by forming hydrogen bonds with the enzyme activities in the cell wall. 2HBC also inhibits microbial growth by binding to enzymes such as phospholipase A2, cyclooxygenase, and lipoxygenase, which are involved in inflammatory processes. This drug also inhibits bacterial growth by binding to the ribosome, preventing protein synthesis and leading to cell death. The inhibition of microbial growth is not limited to bacteria; it also occurs in fungi and protozoa. 2HBC has been shown to be active against both extracellular and intracellular microbial infections.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Naphthalene-2-carboximidamide is a benzamidine derivative that interacts with the active site of serine proteases. It was shown to have potent inhibitory potency against a number of proteinases, including urokinase-type plasminogen activator (uPA), matrix metalloproteinase-9 (MMP-9), and cathepsin G. The interaction of naphthalene-2-carboximidamide with uPA was specific and led to inhibition of its catalytic activity. Naphthalene-2-carboximidamide has been tested in clinical trials for the treatment of influenza.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>